HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancer-Reference-Cited by-全球学者库

HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancer

Published:2019-01-29 Issue:4 Volume:74 Page:578-586
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Tsai Yi-Fang¹²,Tseng Ling-Ming¹²,Lien Pei-Ju¹,Hsu Chih-Yi²³⁴^ORCID,Lin Yen-Shu¹,King Kuang-Liang¹,Wang Yu-Ling¹,Chao Ta-Chung²⁵,Liu Chun-Yu²⁵,Chiu Jen-Hwey¹²,Yang Muh-Hwa²⁵

Affiliation:

1. Comprehensive Breast Health Center and Division of General Surgery; Department of Surgery; Taipei Veterans General Hospital; Taipei Taiwan

2. Institute of Clinical Medicine and Faculty of Medicine; School of Medicine; National Yang-Ming University; Taipei Taiwan

3. Department of Pathology and Laboratory Medicine; Taipei Veterans General Hospital; Taipei Taiwan

4. College of Nursing; National Taipei University of Nursing and Health Sciences; Taipei Taiwan

5. Division of Medical Oncology; Department of Oncology; Taipei Veterans General Hospital; Taipei Taiwan

Funder

Taipei Veterans General Hospital

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.13801/fullpdf

Reference20 articles.

1. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;Arch. Pathol. Lab. Med.,2014

2. Updated UK recommendations for HER2 assessment in breast cancer;Rakha;J. Clin. Pathol.,2015

3. Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer;Allred;Mod. Pathol.,2010

4. High HER2 expression correlates with response to the combination of lapatinib and trastuzumab;Scaltriti;Clin. Cancer Res.,2015

5. Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial;Partridge;J. Clin. Oncol.,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes;International Journal of Molecular Sciences;2023-08-14

2. Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients;2023-06-08

3. Impacts of HER2 immunohistochemical scores on response and outcomes of HER2-positive breast cancers after neoadjuvant therapy;Journal of the Chinese Medical Association;2023-01-23

4. Clinical possibilities of HER2-positive breast cancer diagnosis using alternative scaffold proteins;Bulletin of Siberian Medicine;2022-10-15

5. The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer;Acta Naturae;2022-07-21